CORC

浏览/检索结果: 共11条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs 期刊论文
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 卷号: 150
作者:  Ye, Shandong;  Liu, Jun;  Yang, Wenying;  Miao, Heng;  Ersoy, Canan
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs 期刊论文
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 卷号: 150
作者:  Yang, Wenying;  Ersoy, Canan;  Wang, Guixia;  Ye, Shandong;  Liu, Jun
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/05
Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs 期刊论文
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 卷号: 150, 页码: 158-166
作者:  Yang, Wenying;  Ersoy, Canan;  Wang, Guixia;  Ye, Shandong;  Liu, Jun
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/11
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial 期刊论文
2019, 卷号: 21, 期号: 7, 页码: 1652-1660
作者:  Yang, Wenying;  Ma, Jianhua;  Hong, Tianpei;  Liu, Ming;  Miao, Heng
收藏  |  浏览/下载:16/0  |  提交时间:2020/01/03
Treatment efficacy and glucose variability control of exenatide versus biphasic insulin aspart 30 in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicenter, randomized, open-label, parallel study 会议论文
作者:  Liu, Xiangyang;  Ji, Qiuhe;  Yang, Wenjuan;  Liu, Jianrong;  Gao, Xiling
收藏  |  浏览/下载:4/0  |  提交时间:2019/11/19
A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study 期刊论文
DIABETES OBESITY & METABOLISM, 2018, 卷号: 20, 期号: 12, 页码: 2740-2747
作者:  Guo, Lixin;  Chen, Li;  Chang, Baocheng;  Yang, Liyong;  Liu, Yu
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial 期刊论文
JOURNAL OF DIABETES INVESTIGATION, 2016, 卷号: 7, 期号: 1, 页码: 85-93
作者:  Yang, Wenying;  Zhu, Lvyun;  Meng, Bangzhu;  Liu, Yu;  Wang, Wenhui
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/16
Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-g 期刊论文
2016, 卷号: 7, 期号: 1, 页码: 85-93
作者:  Yang, Wenying;  Zhu, Lvyun;  Meng, Bangzhu;  Liu, Yu;  Wang, Wenhui
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/04
Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A(1)chieve (R) observational study 期刊论文
HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 卷号: 12
作者:  Yang, Wenying;  Zhuang, Xiaoming;  Li, Yukun;  Wang, Qing;  Bian, Rongwen
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/05
Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs: a subgroup analysis of the A(1)chieve study 期刊论文
CHINESE MEDICAL JOURNAL, 2014, 卷号: 127, 期号: 2
作者:  Qin Guijun;  Chen Liming;  Xing Xiaoyan;  Lei Minxiang;  Liu Jie
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace